Danielle LaGrave, MS, LCGC

Phone: 800-242-2787 ext. 2020

Specialties

• Genetics
• Constitutional FISH
• Cytogenetics
• Genomic SNP microarray
• Prenatal cfDNA screening
• Maternal serum screening

Education

• Master’s Degree—Genetic Counseling, California State University, Northridge

Certification/Affiliations

• American Board of Genetic Counseling
• American College of Medical Genetics and Genomics
• National Society of Genetic Counselors
• American Society of Human Genetics

Research Interests

• cfDNA
• Cytogenomic microarray

Recent Publications

• Rose NC, Barrie ES, Malinowski J, et al. Systematic evidence-based review: the application of noninvasive prenatal screening using cell-free DNA in general-risk pregnancies. Genet Med. 2022;24(7):1379-1391.
• Hunsaker JJH, La'ulu SL, LaGrave D, et al. Tobacco and cannabis use during pregnancy. Am J Clin Pathol. 2022;157(1):146-152.
• Martin K, Samango-Sprouse CA, Kantor V, et al. Detection of maternal X chromosome abnormalities using single nucleotide polymorphism-based noninvasive prenatal testing. Am J Obstet Gynecol MFM. 2020;2(3):100152.

Posters

• Bosworth M, Openshaw A, Herdman K, Jenkins M, LaGrave D. Assessing success of a quality improvement process for tracking, reviewing, and correcting constitutional cytogenetic test orders in a reference laboratory, Abstract accepted for poster presentation, 2020 American College of Medical Genetics and Genomics meeting.